诱导化疗

  • 网络induction chemotherapy;Inductive chemotherapy;induced chemotherapy
诱导化疗诱导化疗
  1. TP方案与NP方案诱导化疗联合放疗治疗不可手术的局部晚期非小细胞肺癌

    Results of induction chemotherapy TP and NP regimens followed by radiotherapy in unresectable local advanced non-small cell lung cancer

  2. PVP方案术前诱导化疗治疗口腔颌面部鳞癌的临床研究

    Clinical study of preoperative induction chemotherapy with PVP in the treatment of oral maxillofacial squamous cell carcinoma

  3. N2及N3鼻咽癌诱导化疗的近期疗效观察

    Short Term Effects of Induced Chemotherapy for Nasopharyngeal Cancer of N_2 and N_3

  4. 头颈部癌诱导化疗后细胞凋亡与DNA含量的研究

    Study of apoptosis and DNA statues in head and neck carcinoma with preoperative chemotherapy

  5. DOP及PD方案术前诱导化疗在口腔鳞癌治疗中的应用

    Preoperative Inductive Chemotherapy with DOP or PD Regimen in Oral Squamous Cell Carcinoma

  6. 采用两周期诱导化疗后加放疗的措施。结果:CC组CR率、有效率(CR+PR)分别为36.7%、96.7%。

    Results : The CR and ER of the CC group were 36.7 % and 96.7 % respectively .

  7. 诱导化疗组于放疗前先行PF方案化疗2周期,放疗在化疗结束后2周开始;同步放化疗组在放疗期间共进行PF方案化疗2周期。

    The patients of IC group were treated with PF 2 cycle chemotherapy 2 weeks before radiotherapy .

  8. 口腔颌面部肿瘤CPV方案短疗程术前诱导化疗的临床研究

    Clinical study of preoperative induced chemotherapy with short-term CPV in treatment of oral maxillofacial tumor

  9. 目的:探讨PAF方案(顺铂、阿霉素、5-氟脲嘧啶)术前诱导化疗对口腔鳞癌的临床疗效。

    Objective : To observe the clinical effects of PAF combination preoperative induction chemotherapy for oral squamous cell carcinoma .

  10. TP诱导化疗后同期放化疗治疗局部晚期鼻咽癌27例的Ⅱ期临床试验

    A Phase ⅱ Clinical Trial of Concurrent Chemoradiotherapy after Induction Chemotherapy with TP Regimen in the Treatment for 27 Cases with Locally Advanced Nasopharyngeal Carcinoma

  11. 目的对PVP方案术前诱导化疗治疗口腔鳞癌的近期疗效及安全性进行评价。

    Objective To evaluate the short term effect of preoperative inductive combined chemotherapy with PVP in the treatment of oral squamous cell carcinoma .

  12. 方法:对96例原发、初治急性髓细胞白血病(AML)患者,于诱导化疗第1疗程期间定时作骨髓穿刺检查。

    Methods : Regular bone marrow aspirations were performed during the first course of induction chemotherapy in 96 cases of de novo AML .

  13. 目的评价化疗第6天骨髓象对急性髓性白血病(AML)诱导化疗的指导意义。

    Objective To evaluate the directive function of inductive chemotherapy of the sixth days bone marrow in acute myelogenous leukemia ( AML ) .

  14. ATLS常于诱导化疗后1~5d内发生。

    The ATLS occurs commonly in one to five days after the inductive chemotherapy .

  15. 诱导化疗适宜患者应采用TPF方案治疗。

    Patients who are candidates for induction chemotherapy should be treated with TPF .

  16. 作者报告一例维吾尔族儿童,患弥漫性恶性淋巴瘤(B大无裂细胞性),在诱导化疗后次日晨发生ATLS。

    A Uighur boy with diffuse malignant lymphoma ( B large non-cleave cell type ) suffered ATLS on the next morning after inductive chemotherapy was reported .

  17. 结论:和PF相比,TPF诱导化疗可为局部晚期头颈部鳞癌患者带来长期生存益处。

    INTERPRETATION : Induction chemotherapy with TPF provides long-term survival benefit compared with PF in locally advanced head and neck cancer .

  18. 病人行诱导化疗完全缓解后,采用大剂量联合化疗加小剂量粒细胞集落刺激因子(G-CSF)进行外周造血干细胞动员。

    When 18 patients received mitigation after neoadjuvant chemotherapy , we used huge dose combined chemotherapy plus lower dose G-CSF to mobile peripheral blood .

  19. 口腔癌诱导化疗中P27~(Kip1)表达与细胞周期、凋亡关系的研究

    The relation among P27 ~ ( Kip1 ) expression , cell cycle distribution and apoptosis in oral cancer following induction chemotherapy

  20. 方法:8例非霍奇金淋巴瘤(NHL)多周期诱导化疗达完全缓解后,采用大剂量联合化疗,联合应用小剂量GCSF进行外周造血干细胞的动员。

    Methods : After inductive chemotherapy , the peripheral blood stem cells in the eight patients of non-Hodgkin 's lymphoma ( NHL ) with complete remission were mobilized by high-dose combination chemotherapy and low-dose G-CSF .

  21. 结论HCPT、DDP、5-Fu诱导化疗不能提高晚期鼻咽癌的近期局部控制率,急性不良反应较单纯放疗明显。

    Conclusion HCPT , DDP , 5-FU as inducing chemotherapy can not improve the latest local control rate of advanced nasopharyngeal carcinomas , with distinct side-effect than radiothery alone .

  22. 目的:通过观察诱导化疗前后N0期口腔癌局部肿瘤浸润淋巴细胞表型的改变,初步探讨经皮下埋植泵诱导化疗对口腔癌局部免疫功能的影响。

    Objective : To study the effects of induction chemotherapy via subcutaneous implantable drug pump on local immune status .

  23. 结论:进展期喉癌和咽喉癌患者中,TPF诱导化疗的总体反应率高于PF化疗方案。

    Conclusions : In patients with advanced larynx and hypopharynx carcinomas , TPF induction chemotherapy was superior to the PF regimen in terms of overall response rate .

  24. 临床上不能耐受标准化疗治疗的急性非淋巴细胞性白血病(ANLL)7例,作者称为特殊性ANLL,并应用小剂量足叶乙甙(LD-VP16)诱导化疗。

    Seven patients with special acute nonlymphoblastic leukemia ( ANLL ), being unable to endure the standard chemotherapy , were treated with low-dose etoposide ( LD-VP16 ) .

  25. CAG联合高三尖杉酯碱治疗方案是治疗复发/难治性急性淋巴细胞白血病值得尝试的诱导化疗方案,其疗效较好,使用安全。

    The regimen consisting of CAG and HHT ( Homoharringtonine ) is an worth trying induction regimen for relapse / refractory acute lymphocyte leukemia because of its good curative effect and high security .

  26. 方法初发急性白血病患者45例,诱导化疗结束后用rhIL-11(1.5mg/d)皮下注射,连用14d;

    Methods 45 initial acute leukemia patients were treated with rhIL-11 after the completion of chemotherapy at 1.5 mg / d , injection for 14 days .

  27. 方法:回顾1999年1月~2002年6月在我院应用TPF方案诱导化疗的头颈肿瘤25例。化疗具体实施如下:taxotere75mg/m2,静脉滴注,第1天;

    METHODS : Twenty five cases with head and neck cancers in Guangzhou Tumor Hospital from January 1999 to June 2002 were reviewed .

  28. TP方案诱导化疗后同期TP与DDP治疗局部晚期鼻咽癌的对照研究TP方案化疗对恶性肿瘤患者血糖代谢的影响

    Induction chemotherapy with docetaxel plus cisplatin ( TP regimen ) followed by concurrent chemoradiotherapy with TP regimen versus cisplatin in treating locally advanced nasopharyngeal carcinoma Study on TP chemotherapy regimen induced disorders of glucose metabolism in patients with malignant tumors

  29. 目的研究顺铂(cisplatinCDDP)和5氟脲嘧啶(5fluorouracil,5FU)联合术前诱导化疗对口腔舌鳞癌的抗瘤作用。

    Aim To analyze the role of the anticancer effect of cisplatin ( CDDP ) and 5-fluorouracil ( 5-FU ) combinative chemotherapy in oral squamous carcinoma cell .

  30. 目的探讨米托蒽醌联合阿糖胞苷(MA方案)作为成人初治急性髓细胞性白血病(AML)一线诱导化疗方案的可行性。

    Objective To explore the feasibility of mitoxantrone ( MTZ ) plus cytarabine ( Ara-C ) ( MA regimen ) as the first line therapy in the induction treatment of previously untreated patients with acute myeloid leukemia ( AML ) .